BEONE MEDICINES LTD. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
BEONE MEDICINES LTD. (BEIGF) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$37.60 million for the 3-month period ending 2016-12-31, per its 10-K filed 2017-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2017-03-22
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-12-31 was -$37.60M.
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-09-30 was -$35.49M.
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-06-30 was -$24.12M.
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2016-03-31 was -$22.00M.
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2016 was -$119.22M.
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was -$57.10M.
- BEONE MEDICINES LTD. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$18.55M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$37.60M 10-K · filed 2017-03-22 | -$73.09M derived: sum of 2 quarters · filed 2017-03-22 | -$97.22M derived: sum of 3 quarters · filed 2017-03-22 | -$119.22M 10-K · filed 2017-03-22 |
| 2016-09-30 | -$35.49M 10-K · filed 2017-03-22 | -$59.62M derived: sum of 2 quarters · filed 2017-03-22 | -$81.62M derived: sum of 3 quarters · filed 2017-03-22 | -$108.87M derived: sum of 4 quarters · filed 2017-03-22 |
| 2016-06-30 | -$24.12M 10-K · filed 2017-03-22 | -$46.13M derived: sum of 2 quarters · filed 2017-03-22 | -$73.38M derived: sum of 3 quarters · filed 2017-03-22 | -$87.37M derived: sum of 4 quarters · filed 2017-03-22 |
| 2016-03-31 | -$22.00M 10-K · filed 2017-03-22 | -$49.25M derived: sum of 2 quarters · filed 2017-03-22 | -$63.25M derived: sum of 3 quarters · filed 2017-03-22 | -$68.89M derived: sum of 4 quarters · filed 2017-03-22 |
| 2015-12-31 | -$27.25M 10-K · filed 2017-03-22 | -$41.25M derived: sum of 2 quarters · filed 2017-03-22 | -$46.89M derived: sum of 3 quarters · filed 2017-03-22 | -$57.10M 10-K · filed 2017-03-22 |
| 2015-09-30 | -$14.00M 10-K · filed 2017-03-22 | -$19.64M derived: sum of 2 quarters · filed 2017-03-22 | -$29.85M derived: sum of 3 quarters · filed 2017-03-22 | |
| 2015-06-30 | -$5.64M 10-K · filed 2017-03-22 | -$15.85M derived: sum of 2 quarters · filed 2017-03-22 | ||
| 2015-03-31 | -$10.21M 10-K · filed 2017-03-22 | |||
| 2014-12-31 | -$18.55M 10-K · filed 2017-03-22 |